0.031108 0.000000 0.012166 0.000000 0.109577 0.000000 0.000000 0.000000 0.028270 0.00000 0.00000 0.00000 Bunkoczi, G. Schiell, M. Vertesy, L. Sheldrick, G.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 111.36 90.00 32.146 9.126 37.982 C2 H4 O 44.053 ACETYL GROUP non-polymer C2 H3 O2 -1 59.044 ACETATE ION non-polymer C4 H9 N O2 103.120 n ALPHA-AMINOISOBUTYRIC ACID L-peptide linking C5 H11 N O2 117.146 D-ISOVALINE D-peptide linking C2 H6 O 46.068 ETHANOL non-polymer C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking H2 O 18.015 WATER non-polymer C5 H9 N O3 131.130 n 4-HYDROXYPROLINE HYDROXYPROLINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C9 H13 N O 151.206 n L-PHENYLALANINOL bound form of Phenylalaninal L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking UK J.Pept.Sci. JPSIEI 1225 1075-2617 9 745 10.1002/PSC.496 14658793 Crystal Structures of Cephaibols 2003 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100.0 1 MIRRORS CCD 2002-05-15 BRUKER SMART 6000 SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE BRUKER M06XCE 1669.017 CEPHAIBOL B 2 nat polymer 46.068 ETHANOL 2 syn non-polymer 59.044 ACETATE ION 1 syn non-polymer 18.015 water 26 nat water no yes (ACE)F(AIB)(AIB)(AIB)(DIV)GL(DIV)(AIB)(HYP)Q(DIV)(HYP)(AIB)P(PHL) XFAAAVGLVAPQVPAPF A,B polypeptide(L) n n n n n n n n n n n n n n n n n sample 146077 ACREMONIUM TUBAKII 1 1.54 20 4.60 0.1 M NAAC/HAC PH=4.6, 32% ETOH, pH 4.60 diffrn_detector chem_comp refine struct_conn repository Initial release Atomic model Database references Derived calculations Structure summary Version format compliance Other Data collection Data collection Derived calculations Refinement description Structure summary 1 0 2003-12-11 1 1 2011-07-13 1 2 2012-11-30 1 3 2018-05-30 1 4 2019-05-22 _diffrn_detector.type _chem_comp.pdbx_synonyms _refine.pdbx_ls_cross_valid_method _struct_conn.pdbx_leaving_atom_flag CRYSTAL STRUCTURE OF THE PEPTAIBOL TRICHOTOXIN_A50E SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB IN METHANOL SOLUTION STRUCTURE OF THE PEPTIABOL ZERVAMICIN IIB SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB BOUND TO DPC MICELLES SOLUTION STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I CRYSTAL STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I CRYSTAL STRUCTURE OF THE PEPTAIBOL ALAMETHICIN SOLUTION STRUCTURE OF THE PEPTAIBOL CHRYSOSPERMIN C BOUND TO DPC MICELLES CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL C CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL A PDBE Y PDBE 2003-01-24 REL EOH ETHANOL ACT ACETATE ION HOH water CEPHAIBOL B IS LINEAR PEPTIDE, A MEMBER OF THE PEPTAIBOL FAMILY OF MEMBRANE CHANNEL FORMING PEPTIDES. HERE, CEPHAIBOL B IS REPRESENTED BY THE SEQUENCE (SEQRES) GROUP: 1 NAME: CEPHAIBOL B CHAIN: A, B COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 0 TO 16 DESCRIPTION: CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE. THE N-TERM IS ACETYLATED (RESIDUE 0) Antibiotic CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE. THE N-TERM IS ACETYLATED (RESIDUE 0) Cephaibol B Peptaibol EOH 29 2 EOH EOH 29 A ACT 29 3 ACT ACT 29 B EOH 30 2 EOH EOH 30 B HOH 2001 4 HOH HOH 2001 A HOH 2002 4 HOH HOH 2002 A HOH 2003 4 HOH HOH 2003 A HOH 2004 4 HOH HOH 2004 A HOH 2005 4 HOH HOH 2005 A HOH 2006 4 HOH HOH 2006 A HOH 2007 4 HOH HOH 2007 A HOH 2008 4 HOH HOH 2008 A HOH 2009 4 HOH HOH 2009 A HOH 2010 4 HOH HOH 2010 A HOH 2011 4 HOH HOH 2011 A HOH 2012 4 HOH HOH 2012 A HOH 2013 4 HOH HOH 2013 A HOH 2014 4 HOH HOH 2014 A HOH 2001 4 HOH HOH 2001 B HOH 2002 4 HOH HOH 2002 B HOH 2003 4 HOH HOH 2003 B HOH 2004 4 HOH HOH 2004 B HOH 2005 4 HOH HOH 2005 B HOH 2006 4 HOH HOH 2006 B HOH 2007 4 HOH HOH 2007 B HOH 2008 4 HOH HOH 2008 B HOH 2009 4 HOH HOH 2009 B HOH 2010 4 HOH HOH 2010 B HOH 2011 4 HOH HOH 2011 B HOH 2012 4 HOH HOH 2012 B ACE 0 n 1 ACE 0 A PHE 1 n 2 PHE 1 A AIB 2 n 3 AIB 2 A AIB 3 n 4 AIB 3 A AIB 4 n 5 AIB 4 A DIV 5 n 6 DIV 5 A GLY 6 n 7 GLY 6 A LEU 7 n 8 LEU 7 A DIV 8 n 9 DIV 8 A AIB 9 n 10 AIB 9 A HYP 10 n 11 HYP 10 A GLN 11 n 12 GLN 11 A DIV 12 n 13 DIV 12 A HYP 13 n 14 HYP 13 A AIB 14 n 15 AIB 14 A PRO 15 n 16 PRO 15 A PHL 16 n 17 PHL 16 A ACE 0 n 1 ACE 0 B PHE 1 n 2 PHE 1 B AIB 2 n 3 AIB 2 B AIB 3 n 4 AIB 3 B AIB 4 n 5 AIB 4 B DIV 5 n 6 DIV 5 B GLY 6 n 7 GLY 6 B LEU 7 n 8 LEU 7 B DIV 8 n 9 DIV 8 B AIB 9 n 10 AIB 9 B HYP 10 n 11 HYP 10 B GLN 11 n 12 GLN 11 B DIV 12 n 13 DIV 12 B HYP 13 n 14 HYP 13 B AIB 14 n 15 AIB 14 B PRO 15 n 16 PRO 15 B PHL 16 n 17 PHL 16 B 0.0709 0.0746 0.0706 0.0744 0.0756 0.0793 738 778 5 5 14248 author_and_software_defined_assembly PQS 1 monomeric author_and_software_defined_assembly PQS 1 monomeric A AIB 2 ALPHA-AMINOISOBUTYRIC ACID A AIB 3 ALA A AIB 3 ALPHA-AMINOISOBUTYRIC ACID A AIB 4 ALA A AIB 4 ALPHA-AMINOISOBUTYRIC ACID A AIB 5 ALA A AIB 9 ALPHA-AMINOISOBUTYRIC ACID A AIB 10 ALA A HYP 10 4-HYDROXYPROLINE A HYP 11 PRO A HYP 13 4-HYDROXYPROLINE A HYP 14 PRO A AIB 14 ALPHA-AMINOISOBUTYRIC ACID A AIB 15 ALA A PHL 16 L-PHENYLALANINOL A PHL 17 PHE B AIB 2 ALPHA-AMINOISOBUTYRIC ACID B AIB 3 ALA B AIB 3 ALPHA-AMINOISOBUTYRIC ACID B AIB 4 ALA B AIB 4 ALPHA-AMINOISOBUTYRIC ACID B AIB 5 ALA B AIB 9 ALPHA-AMINOISOBUTYRIC ACID B AIB 10 ALA B HYP 10 4-HYDROXYPROLINE B HYP 11 PRO B HYP 13 4-HYDROXYPROLINE B HYP 14 PRO B AIB 14 ALPHA-AMINOISOBUTYRIC ACID B AIB 15 ALA B PHL 16 L-PHENYLALANINOL B PHL 17 PHE 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 -9.65 1.20 120.10 110.45 B B B CZ CE2 CD2 PHE PHE PHE 1 1 1 B B B N 0.0793 0.0746 0.0744 0.89 35.4 3121 778 16045 4640 5 97.0 THIN SHELLS 1 FREE R-VALUE 0.0 DIRECT METHODS RESTRAINTS FOR AIB, DIV, HYP AND PHL FROM ANTIAMOEBIN (PDB 1JOH) ENGH AND HUBER MOEWS & KRETSINGER 10 252 267.5 0.89 35.4 26 276 10 0 240 0.021 0.040 0.012 0.505 0.131 0.093 0.050 0.006 0.040 0.890 35.400 1OB6 16045 0.04370 1 23.2900 4.440 97.0 0.07860 0.89 1.00 10.370 1 2.16 90.0 refinement SHELXL-97 data reduction SAINT data scaling SADABS phasing SHELXD CEPHAIBOL B Cephaibol B 1 N N 1 N N 2 N N 3 N N 2 N N 4 N N 4 N N A PHE 1 A PHE 2 HELX_P A HYP 10 A HYP 11 1 1 10 B PHE 1 B PHE 2 HELX_P B AIB 9 B AIB 10 1 2 9 B HYP 10 B HYP 11 HELX_P B DIV 12 B DIV 13 5 3 3 covale 1.334 both A ACE 0 A C ACE 1 1_555 A PHE 1 A N PHE 2 1_555 covale 1.348 both A PHE 1 A C PHE 2 1_555 A AIB 2 A N AIB 3 1_555 covale 1.336 both A AIB 2 A C AIB 3 1_555 A AIB 3 A N AIB 4 1_555 covale 1.342 both A AIB 3 A C AIB 4 1_555 A AIB 4 A N AIB 5 1_555 covale 1.332 both A AIB 4 A C AIB 5 1_555 A DIV 5 A N DIV 6 1_555 covale 1.336 both A DIV 5 A C DIV 6 1_555 A GLY 6 A N GLY 7 1_555 covale 1.337 both A LEU 7 A C LEU 8 1_555 A DIV 8 A N DIV 9 1_555 covale 1.336 both A DIV 8 A C DIV 9 1_555 A AIB 9 A N AIB 10 1_555 covale 1.349 both A AIB 9 A C AIB 10 1_555 A HYP 10 A N HYP 11 1_555 covale 1.335 both A HYP 10 A C HYP 11 1_555 A GLN 11 A N GLN 12 1_555 covale 1.328 both A A GLN 11 A C GLN 12 1_555 A DIV 12 A N DIV 13 1_555 covale 1.330 both B A GLN 11 A C GLN 12 1_555 A DIV 12 A N DIV 13 1_555 covale 1.345 both B B A DIV 12 A C DIV 13 1_555 A HYP 13 A N HYP 14 1_555 covale 1.363 both A A A DIV 12 A C DIV 13 1_555 A HYP 13 A N HYP 14 1_555 covale 1.315 both A A A HYP 13 A C HYP 14 1_555 A AIB 14 A N AIB 15 1_555 covale 1.322 both B B A HYP 13 A C HYP 14 1_555 A AIB 14 A N AIB 15 1_555 covale 1.334 both A A A AIB 14 A C AIB 15 1_555 A PRO 15 A N PRO 16 1_555 covale 1.351 both B B A AIB 14 A C AIB 15 1_555 A PRO 15 A N PRO 16 1_555 covale 1.303 both B B A PRO 15 A C PRO 16 1_555 A PHL 16 A N PHL 17 1_555 covale 1.299 both A A A PRO 15 A C PRO 16 1_555 A PHL 16 A N PHL 17 1_555 covale 1.357 both A A B ACE 0 B C ACE 1 1_555 B PHE 1 B N PHE 2 1_555 covale 1.296 both B B B ACE 0 B C ACE 1 1_555 B PHE 1 B N PHE 2 1_555 covale 1.347 both B B B PHE 1 B C PHE 2 1_555 B AIB 2 B N AIB 3 1_555 covale 1.341 both A A B PHE 1 B C PHE 2 1_555 B AIB 2 B N AIB 3 1_555 covale 1.339 both A A B AIB 2 B C AIB 3 1_555 B AIB 3 B N AIB 4 1_555 covale 1.329 both B B B AIB 2 B C AIB 3 1_555 B AIB 3 B N AIB 4 1_555 covale 1.340 both B AIB 3 B C AIB 4 1_555 B AIB 4 B N AIB 5 1_555 covale 1.335 both B AIB 4 B C AIB 5 1_555 B DIV 5 B N DIV 6 1_555 covale 1.347 both B DIV 5 B C DIV 6 1_555 B GLY 6 B N GLY 7 1_555 covale 1.339 both B LEU 7 B C LEU 8 1_555 B DIV 8 B N DIV 9 1_555 covale 1.355 both B DIV 8 B C DIV 9 1_555 B AIB 9 B N AIB 10 1_555 covale 1.347 both B AIB 9 B C AIB 10 1_555 B HYP 10 B N HYP 11 1_555 covale 1.333 both B HYP 10 B C HYP 11 1_555 B GLN 11 B N GLN 12 1_555 covale 1.336 both B GLN 11 B C GLN 12 1_555 B DIV 12 B N DIV 13 1_555 covale 1.360 both B DIV 12 B C DIV 13 1_555 B HYP 13 B N HYP 14 1_555 covale 1.313 both B HYP 13 B C HYP 14 1_555 B AIB 14 B N AIB 15 1_555 covale 1.357 both B AIB 14 B C AIB 15 1_555 B PRO 15 B N PRO 16 1_555 covale 1.316 both B PRO 15 B C PRO 16 1_555 B PHL 16 B N PHL 17 1_555 ANTIBIOTIC CEPHAIBOL, PEPTAIBOL, ANTIBACTERIAL, ANTIFUNGAL, ION CHANNEL, ANTIBIOTIC given 0.994460 0.016940 0.103710 -0.016340 0.999840 -0.006660 -0.103810 0.004930 0.994580 19.39953 5.28985 -19.99939 NOR00971 NOR 1 NOR00971 0 16 1OB6 0 16 NOR00971 A 1 1 17 0 16 1OB6 0 16 NOR00971 B 1 1 17 BINDING SITE FOR RESIDUE ACT B 29 Software 3 BINDING SITE FOR RESIDUE EOH A 29 Software 4 BINDING SITE FOR RESIDUE EOH B 30 Software 4 BINDING SITE FOR CHAIN A OF CEPHAIBOL B Software 26 BINDING SITE FOR CHAIN B OF CEPHAIBOL B Software 25 A PHE 1 A PHE 2 3 1_446 B PRO 15 B PRO 16 3 1_555 B EOH 30 E EOH 3 1_555 A GLY 6 A GLY 7 4 1_555 A HYP 10 A HYP 11 4 1_555 A HOH 2001 F HOH 4 1_565 A HOH 2006 F HOH 4 1_555 A ACE 0 A ACE 1 4 1_446 B PHL 16 B PHL 17 4 1_545 B ACT 29 D ACT 4 1_555 B HOH 2011 G HOH 4 1_545 A EOH 29 C EOH 26 1_555 A HOH 2001 F HOH 26 1_555 A HOH 2004 F HOH 26 1_555 A HOH 2005 F HOH 26 1_555 A HOH 2005 F HOH 26 1_545 A HOH 2006 F HOH 26 1_555 A HOH 2007 F HOH 26 1_555 A HOH 2008 F HOH 26 1_545 A HOH 2008 F HOH 26 1_555 A HOH 2009 F HOH 26 1_555 A HOH 2010 F HOH 26 1_555 A HOH 2011 F HOH 26 1_565 A HOH 2011 F HOH 26 1_555 A HOH 2012 F HOH 26 1_555 A HOH 2013 F HOH 26 1_555 B ACE 0 B ACE 1 26 1_565 B ACE 0 B ACE 1 26 1_555 B PHE 1 B PHE 2 26 1_555 B AIB 2 B AIB 3 26 1_555 B AIB 14 B AIB 15 26 1_664 B PRO 15 B PRO 16 26 1_664 B PHL 16 B PHL 17 26 1_664 B ACT 29 D ACT 26 1_664 B EOH 30 E EOH 26 1_664 B HOH 2001 G HOH 26 1_565 B HOH 2011 G HOH 26 1_654 A ACE 0 A ACE 1 25 1_446 A PHE 1 A PHE 2 25 1_446 A AIB 2 A AIB 3 25 1_446 A AIB 14 A AIB 15 25 1_555 A PRO 15 A PRO 16 25 1_555 A PHL 16 A PHL 17 25 1_545 A PHL 16 A PHL 17 25 1_555 A HOH 2002 F HOH 25 1_555 A HOH 2012 F HOH 25 1_555 A HOH 2013 F HOH 25 1_555 A HOH 2014 F HOH 25 1_555 B ACT 29 D ACT 25 1_555 B EOH 30 E EOH 25 1_565 B HOH 2002 G HOH 25 1_555 B HOH 2003 G HOH 25 1_555 B HOH 2004 G HOH 25 1_555 B HOH 2005 G HOH 25 1_555 B HOH 2006 G HOH 25 1_555 B HOH 2007 G HOH 25 1_545 B HOH 2007 G HOH 25 1_555 B HOH 2008 G HOH 25 1_555 B HOH 2009 G HOH 25 1_555 B HOH 2010 G HOH 25 1_555 B HOH 2011 G HOH 25 1_555 B HOH 2012 G HOH 25 1_555 4 P 1 21 1